肺气肿型慢性阻塞性肺疾病并发肺癌的危险因素分析

doi:10.3969/j.issn.1001-8131.2026.01.003

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (741 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To examine the risk factors associated with lung cancer in individuals with chronic obstructive pulmonary disease(COPD)who also have emphysema. Methods A total of 318 patients with emphysema type COPD admitted to our hospital from June.According to the results of histopathological examination,they were divided into lung cancer group(33 cases)and non-lung cancer group(285 cases).The clinical data of the two groups were compared,and binary logistic regression analysis was used to screen the independent risk factors of emphysematous COPD complicated with lung cancer. Results The comparison of basic clinical data between two groups of COPD patients with emphysema showed that there were statistically significant differences in gender,age,smoking index,COPD duration,persistent chest pain,and hemoptysis between patients with concurrent lung cancer and those without concurrent lung cancer(P<0.05).The binary logistic regression analysis showed that age,smoking index,COPD duration,persistent chest pain,and hemoptysis are independent risk factors for pulmonary emphysema COPD complicated with lung cancer,which can increase the risk of concurrent lung cancer by 3.30 times,5.30 times,3.20 times,4.12 times,and 3.64 times,respectively(P<0.05). Conclusion Age,smoking index,COPD duration,persistent chest pain,and hemoptysis are independent risk factors for lung cancer in COPD with emphysema,which can increase the risk of lung cancer by 3.30 times,5.30 times,3.20 times,4.12 times,and 3.64 times,respectively.Therefore,comprehensive preventive measures should be taken,including quitting smoking,actively treating COPD,and regularly undergoing chest X-rays or CT scans,in order to reduce the risk of developing lung cancer and improve the quality of life of patients.

Key words： Chronic obstructive pulmonary disease Emphysema Lung cancer Risk factors

Received: 03 February 2026

PACS:

R734.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Yang Zhilu
	Sha ZhengKai
	Zhang Xiangjie
	Zhang Pan
	Liu Xiaoxiao

Cite this article:

Yang Zhilu,Sha ZhengKai,Zhang Xiangjie, et al. Analysis of Risk Factors for Lung Cancer in Chronic Obstructive Pulmonary Disease with Emphysema Type[J]. journal1, 2026, 46(1): 8-12.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2026.01.003 OR http://www.hrbyybjb.org.cn/EN/Y2026/V46/I1/8

[1] Verleden S E,Hendriks J M H,Snoeckx A,et al.Small Airway Disease in Pre-Chronic Obstructive Pulmonary Disease with Emphysema:A Cross-Sectional Study[J].American journal of respiratory and critical care medicine,2024,209(6),683-692.
[2] 杨志路,沙正凯,张祥杰,等.血循环肿瘤细胞水平与肺气肿型慢性阻塞性肺疾病并发肺癌的关系[J].中国现代医药杂志,2025,27(06):29-35.
[3] 张瑶,刘学军.老年慢性阻塞性肺疾病合并肺癌筛查评分模型建立及相关血清学标志物研究[J].国际呼吸杂志,2022,42(1):62-66.
[4] Booth S,Hsieh A,Mostaco-Guidolin L,et al.A Single-Cell Atlas of Small Airway Disease in Chronic Obstr-uctive Pulmonary Disease:A Cross-Sectional Study[J].American journal of respiratory and critical care medicine,2023,208(4),472-486.
[5] 康淑琴,董向月,马娟,等.高分辨率CT肺气肿指标联合血清CEA、NLR、PLR对慢性阻塞性肺疾病患者非小细胞肺癌发生风险的预测价值[J].现代生物医学进展,2024,24(14):2785-2789.
[6] 马红红,王曦,谢欣芸,等.血清sRAGE联合肺功能及肺HRCT预测慢性阻塞性肺疾病发生非小细胞肺癌风险的价值[J].中国呼吸与危重监护杂志,2023,22(7):457-463.
[7] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会.慢性阻塞性肺疾病诊治指南(2021年修订版)[J].中华结核和呼吸杂志,2021,44(03):170-205.
[8] Osundolire S,Goldberg RJ,Lapane KL.Descriptive Epide-miology of Chronic Obstructive Pulmonary Disease in US Nursing Home Residents With Heart Failure[J].Curr Probl Cardiol,2023,48(2):101484.
[9] 徐双兰,陈子,杨姣,等.气道上皮细胞Src同源区2蛋白酪氨酸磷酸酶1基因敲除对慢性阻塞性肺疾病肺气肿表型的影响[J].中华结核和呼吸杂志,2024,47(4):339-345.
[10] Leiter A,Veluswamy RR,Wisnivesky JP.The global burden of lung cancer:current status and future trends[J].Nat Rev Clin Oncol,2023,20(9):624-639.
[11] 蔡国森,谭薇,吉林,等.右美托咪定在老年肺癌合并COPD患者中的麻醉效果及对应激反应和Th1、Th2型细胞因子的影响[J].现代生物医学进展,2024,24(11):2177-2181.
[12] 刘敏,杨柳.不同病理类型的肺癌合并慢性阻塞性肺疾病的临床特征及对患者预后的提示意义[J].中国实验诊断学,2024,28(5):515-519.
[13] 邹晨曦,徐轶,韩盈盈,等.吸烟对驱动基因阴性非小细胞肺癌患者免疫检查点抑制药疗效的影响[J].中国临床药理学杂志,2023,39(10):1397-1401.
[14] 包萨日娜,李武武,李雅萌.不同吸烟状况非小细胞肺癌患者临床特征及表皮生长因子受体突变研究[J].创伤与急危重病医学,2023,11(5):363-366.
[15] 涂秀华,雷妹,俞慧琴,等.老年非小细胞肺癌患者术后肺部并发症的影响因素及其短期预后研究[J].中华实验外科杂志,2024,41(8):1683-1686.
[16] 包萨日娜,李武武,李雅萌.不同吸烟状况非小细胞肺癌患者临床特征及表皮生长因子受体突变研究[J].创伤与急危重病医学,2023,11(5):363-366.
[17] 孙爽,付晗,安杨,等.吸入型糖皮质激素对中老年中重度慢性阻塞性肺疾病患者肺癌发生风险的影响[J].中国临床保健杂志,2022,25(3):319-321.
[18] 黄波,丁洁,郭红荣,等.低氧条件下SIRT3调控ROS介导的氧化应激反应对肺癌细胞凋亡的影响[J].安徽医科大学学报,2023,58(12):2045-2050,2057.
[19] Oncology Society Of Chinese Medical Association.Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer(2022 edition)[J].Zhonghua Zhong liu Za Zhi.2022,44(6):457-490.
[20] 秦士想,叶永青.慢性阻塞性肺疾病合并肺癌的临床特点分析及列线图预测模型的建立[J].临床肺科杂志,2023,28(11):1682-1686.